Endo International (ENDP) Tops Q3 EPS by 12c, Guidance Tops Views
Tweet
Share
E-mail
Get Alerts ENDP Hot Sheet
Price: $0.29 --0%
Financial Fact:
Net pharmaceutical product sales: 422.03M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net pharmaceutical product sales: 422.03M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Endo International (NASDAQ: ENDP) reported Q3 EPS of $0.71, $0.12 better than the analyst estimate of $0.59. Revenue for the quarter came in at $745 million versus the consensus estimate of $694.93 million.
GUIDANCE:
Endo International sees FY2018 EPS of $2.65-$2.75, versus the consensus of $2.60. Endo International sees FY2018 revenue of $2.87-2.92 billion, versus the consensus of $2.81 billion.
For earnings history and earnings-related data on Endo International (ENDP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
